Larvol Delta - PARP-Inhibitor-Olaparib-Causes-No-Potentiation-of-the-Bleomycin-Effect-in-VERO-Cells-Even-in-the-Presence-of-Pooled-ATM-DNAPK-and-LigIV-Inhibitors

bleomycin - Generic mfg.

KU-55933 - AstraZeneca

Lynparza (olaparib) - Merck (MSD), AstraZeneca

KU-0060648 - Axon Medchem

http://www.ncbi.nlm.nih.gov/pubmed/33167404

Nov 12, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next